187 related articles for article (PubMed ID: 16328685)
41. Percutaneous image-guided radiofrequency thermal ablation for large symptomatic uterine leiomyomata after uterine artery embolization: a feasibility and safety study.
Kim HS; Tsai J; Jacobs MA; Kamel IR
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):41-8. PubMed ID: 17296703
[TBL] [Abstract][Full Text] [Related]
42. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
43. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients.
Jakobs TF; Hoffmann RT; Trumm C; Reiser MF; Helmberger TK
Anticancer Res; 2006; 26(1B):671-80. PubMed ID: 16739337
[TBL] [Abstract][Full Text] [Related]
44. [Clinical value of CT guided radiofrequency ablation in treatment of post-operational resectable liver metastatic tumor from colorectal carcinoma].
Gu YK; Wu PH; Fan WJ; Huang JH; Zhang L; Gao F
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2748-50. PubMed ID: 19080447
[TBL] [Abstract][Full Text] [Related]
45. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
[TBL] [Abstract][Full Text] [Related]
46. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
Linden PA; Wee JO; Jaklitsch MT; Colson YL
Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
[TBL] [Abstract][Full Text] [Related]
47. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience.
Yamakado K; Nakatsuka A; Kobayashi S; Akeboshi M; Takaki H; Kariya Z; Kinbara H; Arima K; Yanagawa M; Hori Y; Kato H; Sugimura Y; Takeda K
Cardiovasc Intervent Radiol; 2006; 29(3):389-94. PubMed ID: 16502180
[TBL] [Abstract][Full Text] [Related]
48. [Flexible applicator systems for radiofrequency ablation (RFA) of hepatic tumors].
Gebauer B; Gaffke G; Hünerbein M; Felix R; Stroszczynski C
Rofo; 2003 Dec; 175(12):1720-3. PubMed ID: 14661145
[TBL] [Abstract][Full Text] [Related]
49. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
[TBL] [Abstract][Full Text] [Related]
50. Solitary colorectal liver metastasis: resection determines outcome.
Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
[TBL] [Abstract][Full Text] [Related]
51. [Mathematical protocol for radiofrequency ablation of liver tumors and its clinical application].
Chen MH; Yang W; Yan K; Zou MW; Dai Y; Gao W; Zhang XP; Huang XF
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):203-8. PubMed ID: 15059535
[TBL] [Abstract][Full Text] [Related]
52. [Local recurrence following hepatic radiofrequency ablation: diagnosis and treatment].
Eisele RM; Schumacher G; Neuhaus P
Strahlenther Onkol; 2008 Nov; 184(11):598-604. PubMed ID: 19016019
[TBL] [Abstract][Full Text] [Related]
53. [Radio-frequency ablation therapy for metastatic liver tumors from colorectal carcinoma].
Katsumoto Y; Yasumoto T; Maruyama K; Nagai K; Seshimo I; Yokoyama S; Yoneda K; Murata K; Yokouchi H; Kinuta M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1670-2. PubMed ID: 16315904
[TBL] [Abstract][Full Text] [Related]
54. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
55. Radiofrequency ablation of invasive breast carcinomas: a phase II trial.
Medina-Franco H; Soto-Germes S; Ulloa-Gómez JL; Romero-Trejo C; Uribe N; Ramirez-Alvarado CA; Robles-Vidal C
Ann Surg Oncol; 2008 Jun; 15(6):1689-95. PubMed ID: 18363072
[TBL] [Abstract][Full Text] [Related]
56. MR appearances of radiofrequency thermal ablation region: histopathologic correlation with dog liver models and an autopsy case.
Onishi H; Matsushita M; Murakami T; Tono T; Okamoto S; Aoki Y; Iannaccone R; Hori M; Kim T; Osuga K; Tomoda K; Passariello R; Nakamura H
Acad Radiol; 2004 Oct; 11(10):1180-9. PubMed ID: 15530812
[TBL] [Abstract][Full Text] [Related]
57. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
58. Radiofrequency ablation is useful for selected cases of pelvic recurrence of rectal carcinoma.
Ohhigashi S; Watanabe F
Tech Coloproctol; 2003 Oct; 7(3):186-91. PubMed ID: 14628164
[TBL] [Abstract][Full Text] [Related]
59. Therapy monitoring of magnetic resonance-guided radiofrequency ablation using T1- and T2-weighted sequences at 1.5 T: reliability of estimated ablation zones.
Rempp H; Unterberg J; Hoffmann R; Pereira PL; Schick F; Claussen CD; Clasen S
Invest Radiol; 2013 Jun; 48(6):429-36. PubMed ID: 23511192
[TBL] [Abstract][Full Text] [Related]
60. Radiofrequency ablated lesion in the normal porcine lung: long-term follow-up with MRI and pathology.
Oyama Y; Nakamura K; Matsuoka T; Toyoshima M; Yamamoto A; Okuma T; Ikura Y; Ueda M; Inoue Y
Cardiovasc Intervent Radiol; 2005; 28(3):346-53. PubMed ID: 15886942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
